We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Molecular Diagnostics

Image: The GNRI diagnostic system is easy to use, rapid and sensitive (Photo courtesy of Unsplash)

POC Sepsis Diagnostic Platform to Speed up Clinical and Treatment Decision Making

Great North Research & Innovation (GNRI, Newcastle Upon Tyne, UK) is building a patient focused tool to assist clinicians in determining the causative pathogens in sepsis rapidly and accurately. More...
06 Apr 2022
Image: Voice-activated pipettes use AI to offer workflow benefits (Photo courtesy of INTEGRA Biosciences)

AI-Powered Voice-Activated Pipettes Streamline Processes and Increase Lab Productivity

Voice-activated pipettes are now set to become the future of pipetting. INTEGRA Biosciences (Zizers, Switzerland) has made its first foray into the world of artificial intelligence with the release of voice-activated pipettes that are designed to offer workflow benefits far beyond simplifying pipetting tasks. More...
06 Apr 2022
Image: Li-Fraumeni Syndrome: a) High-grade invasive ductal carcinoma with p53 overexpression; b) mutant pattern in a patient with a germline TP53 missense mutation (Photo courtesy of Brigham and Women’s Hospital)

Liquid Biopsy Enables Early Cancer Detection in Li-Fraumeni Syndrome Patients

Patients with Li-Fraumeni Syndrome (LFS) harbor germline pathogenic variants in the TP53 gene causing predisposition to many cancers from childhood through late adulthood and can accelerate the onset of cancer by more than 30 years. More...
05 Apr 2022
Image: World-first bedside genetic test could prevent babies going deaf (Photo courtesy of The University of Manchester)

World-First Bedside Genetic Test Identifies Susceptibility to Deafness in Newborn Babies

A new bedside machine takes just 25 minutes to identify whether a critically ill baby admitted to intensive care has a gene that could result in permanent hearing loss if they are treated with a common emergency antibiotic. More...
05 Apr 2022
Image: World-first bedside genetic test could prevent babies going deaf (Photo courtesy of The University of Manchester)

World-First Bedside Genetic Test Identifies Susceptibility to Deafness in Newborn Babies

A new bedside machine takes just 25 minutes to identify whether a critically ill baby admitted to intensive care has a gene that could result in permanent hearing loss if they are treated with a common emergency antibiotic. More...
05 Apr 2022
Image: Proteins could one day allow breast cancer screening to be done with a blood test (Photo courtesy of Unsplash)

Blood Test to Detect Protein Biomarkers Identified Using Breast Milk Could Enable Breast Cancer Screening

A simple blood test for women of all ages and risk levels could one day be possible thanks to a new set of protein biomarkers identified by researchers using breast milk. The newly identified biomarkers are for a specific type of cancer called invasive ductal carcinoma (IDC), one of the most common types of breast cancers, but the approach could be used to identify biomarkers for other types of breast cancer as well. More...
05 Apr 2022
Image: Dementia, which can be caused by buildup of toxic molecules, cause brain injury, loss of memory and decline in intelligence (Photo courtesy of 123rf.com)

Newly Identified Biomarkers Detect Subcortical Small-vessel Disease

Biomarkers have been identified that were able to differentiate between classical Alzeheimer’s disease and subcortical small-vessel disease (SSVD), which is the most common vascular cognitive disorder. More...
04 Apr 2022
New
Gold Member
Automatic Hematology Analyzer
CF9600
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Thyroid Test
Anti-Thyroid EIA Test
New
Automatic CLIA Analyzer
Shine i6000


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.